Literature DB >> 24728901

Extensive intracranial involvement with multiple dissections in a case of giant cell arteritis.

Joana Parra1, Joana Domingues, João Sargento-Freitas, Isabel Santana.   

Abstract

A 56-year-old man presented with weight loss, articular pain and minor neurological symptoms progressing over 1 month. Neurosonological evaluation suggested occlusion in intracranial segments of the left vertebral artery (VA) and of both internal carotid arteries (ICA) and hypoechoic halo sign in both superficial temporal arteries. The diagnosis of giant cell arteritis was supported by inflammatory markers and confirmed by biopsy. Despite early steroid initiation, he manifested fluctuant vascular deficits and became lethargic. Brain MRI indicated watershed infarcts and intracranial dissections of left VA and both ICA. The patient was stabilised with the association of prednisolone 2 mg/kg, methotrexate and oral anticoagulation. Since then he has been neurologically asymptomatic and control imaging showed only residual intracranial left VA stenosis, with no signs of temporal artery inflammation or new vascular lesions. This is to the best of our knowledge, the first reported clinical case with such an extensive intracranial involvement with multiple dissections.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24728901      PMCID: PMC3987556          DOI: 10.1136/bcr-2014-204130

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  BSR and BHPR guidelines for the management of giant cell arteritis.

Authors:  Bhaskar Dasgupta; Frances A Borg; Nada Hassan; Leslie Alexander; Kevin Barraclough; Brian Bourke; Joan Fulcher; Jane Hollywood; Andrew Hutchings; Pat James; Valerie Kyle; Jennifer Nott; Michael Power; Ash Samanta
Journal:  Rheumatology (Oxford)       Date:  2010-04-05       Impact factor: 7.580

Review 2.  Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment.

Authors:  Andrea T Borchers; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2012-01-21       Impact factor: 9.754

3.  Diagnosis and treatment of cerebral vasculitis.

Authors:  Peter Berlit
Journal:  Ther Adv Neurol Disord       Date:  2010-01       Impact factor: 6.570

4.  Giant cell arteritis: Involvement of intracranial arteries.

Authors:  Carlo Salvarani; Caterina Giannini; Dylan V Miller; Gene Hunder
Journal:  Arthritis Rheum       Date:  2006-12-15

Review 5.  The clinical utility of high resolution magnetic resonance imaging in the diagnosis of giant cell arteritis: a critically appraised topic.

Authors:  Julie A Khoury; Joseph M Hoxworth; Mehrdad Mazlumzadeh; Kay E Wellik; Dean M Wingerchuk; Bart M Demaerschalk
Journal:  Neurologist       Date:  2008-09       Impact factor: 1.398

Review 6.  An atypical presentation of giant cell arteritis.

Authors:  Jocelyn Zwicker; Edward J Atkins; Cheemun Lum; Mukul Sharma
Journal:  CMAJ       Date:  2011-02-07       Impact factor: 8.262

7.  Assessment of the cranial involvement pattern of giant cell arteritis with 3T magnetic resonance imaging.

Authors:  T A Bley; O Weiben; M Uhl; P Vaith; D Schmidt; K Warnatz; M Langer
Journal:  Arthritis Rheum       Date:  2005-08

8.  Antiplatelet and anticoagulant therapy in patients with giant cell arteritis.

Authors:  Michael S Lee; Scott D Smith; Anat Galor; Gary S Hoffman
Journal:  Arthritis Rheum       Date:  2006-10

9.  Lethal giant cell arteritis with multiple ischemic strokes despite aggressive immunosuppressive therapy.

Authors:  Christine Lu-Emerson; Melanie Walker; Bertrand R Huber; Basavaraj Ghodke; W T Longstreth; Sandeep P Khot
Journal:  J Neurol Sci       Date:  2010-06-17       Impact factor: 3.181

10.  Disease pattern in cranial and large-vessel giant cell arteritis.

Authors:  A Brack; V Martinez-Taboada; A Stanson; J J Goronzy; C M Weyand
Journal:  Arthritis Rheum       Date:  1999-02
View more
  4 in total

1.  Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis.

Authors:  Don Gilden; Teresa White; Nelly Khmeleva; Anna Heintzman; Alexander Choe; Philip J Boyer; Charles Grose; John E Carpenter; April Rempel; Nathan Bos; Balasubramaniyam Kandasamy; Kelly Lear-Kaul; Dawn B Holmes; Jeffrey L Bennett; Randall J Cohrs; Ravi Mahalingam; Naresh Mandava; Charles G Eberhart; Brian Bockelman; Robert J Poppiti; Madhura A Tamhankar; Franz Fogt; Malena Amato; Edward Wood; Vikram Durairaj; Steve Rasmussen; Vigdis Petursdottir; Lea Pollak; Sonia Mendlovic; Denis Chatelain; Kathy Keyvani; Wolfgang Brueck; Maria A Nagel
Journal:  Neurology       Date:  2015-02-18       Impact factor: 9.910

2.  Widespread arterial infection by varicella-zoster virus explains refractory giant cell arteritis.

Authors:  Don Gilden; Teresa White; Steven L Galetta; Franz Fogt; Maria A Nagel
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-06-04

3.  Giant cell arteritis with rare manifestations of stroke and internal carotid artery dissection: A case study.

Authors:  Leila Hashami; Arsh Haj Mohamad Ebrahim Ketabforoush; Matineh Nirouei
Journal:  Clin Case Rep       Date:  2022-03-20

4.  Association of antinuclear antibodies with the risk of intracranial arterial stenosis.

Authors:  Yong-An Sun; Qiu Han; Xiao-He Hou; Xian-Zhen Peng; Lin Tong; Xu Zheng; Jin-Tai Yu; Lan Tan
Journal:  Aging (Albany NY)       Date:  2020-01-21       Impact factor: 5.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.